VW

Vipin Wadhwa

Active Director Director DIN 02668021
DIN 02668021 First appointment Dec 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2005
Shareholding value •••• Premium profile

About Vipin Wadhwa

Data last updated:

Vipin Wadhwa is a Director at Globin Pharmaceuticals Private Limited (since 2005). The company operates in Pharma. Globin Pharmaceuticals Private Limited reported revenue of ₹18.48 Cr (FY 2024).

DIN 02668021
Primary Designation Director
Industry Pharma
First Appointment 22 Dec 2005
Oldest Company Age 26 yrs
Largest company Globin Pharmaceuticals Private Limited · ₹18.48 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Dec 20052000₹18.48 Cr (FY 2024)Active

Board colleagues of Vipin Wadhwa

NameDINCompanyDesignation
Sanjay Wadhwa00784043Globin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vipin Wadhwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipin Wadhwa

Vipin Wadhwa currently holds 1 directorship: Globin Pharmaceuticals Private Limited (Director, since 22 Dec 2005, revenue ₹18.48 Cr (FY 2024)).

Vipin Wadhwa was first appointed on 22 Dec 2005 as Director at Globin Pharmaceuticals Private Limited.

The current boards of Vipin Wadhwa's companies include Sanjay Wadhwa (Globin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available